Phase II trial of Vitamin B6 for the HFS related to Capecitabine in adjuvant setting ( in Stage III colon cancer). - Phase II trial of Vitamin B6 for the HFS related to Capecitabine in adjuvant setting ( in Stage III colon cancer).

Tohoku University Graduate School of Medicine0 个研究点目标入组 30 人开始时间: 2010年9月8日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1.Multiple cancer patient (within 5 years) 2.Severe infection or serious complications, such as hypoalimentation 3.Serious postoperative complications are not restored by registration 4. Have following complications I) Uncontrollable diabetes II) Uncontrollable hypertension III) The cirrhosis of the liver 5.Judged by the investigator to be unfit in the study for abnormality of the electrocardiogram, abnormal cardiac function having a history of serious heart trouble 6.Upper part digestive organs disorder or absorption disorder 7.Pregnancy, lactation woman, or woman with suspected pregnancy 8.Severe mental disease 9.Any subject judged by the investigator to be unfit for any reason to participate in the study

发起方

Tohoku University Graduate School of Medicine